Andrew R. Jordan

Insider Reports History

Entity: Individual
Location: C/O Guilford Pharmaceuticals Inc, 6611 Tibutary St., Baltimore, MD
Signature: /s/ John J. Kirby, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew R. Jordan:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Aceragen, Inc.	CHIEF STRATEGY OFFICER	Common Stock	452K	$230K	$0.51	Jan 17, 2023	Direct
Aceragen, Inc.	CHIEF STRATEGY OFFICER	Stock Options (Right to Buy)	25.4K			Jan 20, 2023	Direct
Aceragen, Inc.	CHIEF STRATEGY OFFICER	Series Z Convertible Preferred Stock	0			Jan 17, 2023	Direct

Showing 1 to 3 of 3 entries

Insider Reports Filed by Andrew R. Jordan

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
ACGN	Aceragen, Inc.	Jan 20, 2023	1	$0	4	Feb 2, 2023	CHIEF STRATEGY OFFICER
ACGN	Aceragen, Inc.	Jan 17, 2023	2	$0	4	Jan 19, 2023	Chief Strategy Officer
IDRA	IDERA PHARMACEUTICALS, INC.	Jan 6, 2023	2	-$52.5K	4	Jan 10, 2023	CHIEF STRATEGY OFFICER
IDRA	IDERA PHARMACEUTICALS, INC.	Sep 28, 2022	2	$0	4	Sep 30, 2022	Chief Strategy Officer
IDRA	IDERA PHARMACEUTICALS, INC.	Sep 28, 2022	0	$0	3	Sep 30, 2022	Chief Strategy Officer